Chrysin as a Bioactive Scaffold: Advances in Synthesis and Pharmacological Evaluation
International Journal of Molecular Sciences · 27.09.2025 · 26 (19) · 9467
DOI: 10.3390/ijms26199467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.09.2025. Verfasst von Chae Yun Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Applied Chemistry, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Flavonoids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Chrysin (5,7-dihydroxyflavone) is a flavonoid widely distributed in propolis, honey, and various plant sources. It exhibits a wide range of pharmacological activities, including anti-inflammatory, antioxidant, anticancer, antimicrobial, and anti-diabetic effects. However, its clinical translation is hampered by poor aqueous solubility, low bioavailability, and rapid metabolic clearance. To address these limitations and expand the chemical space of this natural scaffold, extensive synthetic efforts have focused on generating structurally diverse chrysin derivatives that possess improved drug-like properties. This review systematically categorizes synthetic methodologies—such as etherification, esterification, transition-metal-mediated couplings, sigmatropic rearrangements, and electrophilic substitutions—and integrates them with corresponding biological outcomes. Particular emphasis is placed on recent (2020–present) advances that directly link structural modifications with pharmacological enhancements, thereby offering comparative structure–activity relationship (SAR) insights. In addition, transition-metal-catalyzed C–C bond-forming reactions are highlighted in a dedicated section, underscoring their growing role in accessing bioactive chrysin analogs previously unattainable by conventional chemistry. Unlike prior reviews that mainly summarized biological activities or broadly covered flavonoid scaffolds, this article bridges synthetic diversification with pharmacological evaluation. It provides both critical synthesis and mechanistic interpretation. Overall, this work consolidates current knowledge and suggests future directions that integrate synthetic innovation with pharmacological validation and address pharmacokinetic challenges in chrysin derivatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering and Applied Chemistry, Kyungpook National University, Daegu 41566, Republic of Korea.
- Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 56212, Republic of Korea.
ORCID-Profile: Jongho Jeon
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jeong, C. Y., Kim, C. E., Byun, E. B., & Jeon, J. (2025). Chrysin as a Bioactive Scaffold: Advances in Synthesis and Pharmacological Evaluation. International Journal of Molecular Sciences, 26(19), 9467. https://doi.org/10.3390/ijms26199467
Vancouver
Jeong CY, Kim CE, Byun EB, Jeon J. Chrysin as a Bioactive Scaffold: Advances in Synthesis and Pharmacological Evaluation. International Journal of Molecular Sciences. 2025;26(19):9467. doi:10.3390/ijms26199467
BibTeX
@article{Jeong2025,
author = {Jeong, Chae Yun and Kim, Chae-Eun and Byun, Eui-Baek and Jeon, Jongho},
title = {Chrysin as a Bioactive Scaffold: Advances in Synthesis and Pharmacological Evaluation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9467},
doi = {10.3390/ijms26199467}
}
EUVIMED